Dorien Haesen

1.0k citations
8 papers · 637 indexed · h-index 8
Topics
Ubiquitin and proteasome pathways (6 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)
Partner nations
BelgiumSpainFinland

In The Last Decade

Dorien Haesen

8 papers receiving 636 citations

Peers

Dorien Haesen
Comparison fields: 5 of 81
  • Molecular Biology 495
  • Oncology 106
  • Cancer Research 96
  • Cell Biology 80
  • Genetics 50
Replace Stela S. Palii with:
Stela S. Palii United States
Cheng-Fu Kao Taiwan
Maria Shvedunova Germany
Gastón Soria Argentina
Kasey Jividen United States
Eun Jeong Kwon South Korea
Daniela Bressanin Italy
Qi-Heng Yang United States
Soňa Legartová Czechia
Emily Hsu United States
Dorien Haesen relative to Stela S. Palii United States Stela S. Palii's profile →
Citations per field
00.5×4.5×
Stela S. Palii · 1×
Citations per year

Countries citing papers authored by Dorien Haesen

Since Specialization
Citations

This map shows the geographic impact of Dorien Haesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorien Haesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorien Haesen more than expected).

Fields of papers citing papers by Dorien Haesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorien Haesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorien Haesen. The network helps show where Dorien Haesen may publish in the future.

Co-authorship network of co-authors of Dorien Haesen

This figure shows the co-authorship network connecting the top 25 collaborators of Dorien Haesen. A scholar is included among the top collaborators of Dorien Haesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorien Haesen. Dorien Haesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 31
2 144
3 17
4 86
5 59
6 107
7
Cellular inhibitors of Protein Phosphatase PP2A in cancer.
24
8 169

About Dorien Haesen

Dorien Haesen is a scholar working on Molecular Biology, Oncology and Cancer Research, having authored 8 papers that have together received 637 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Molecular Biology (495 citations), Cancer Research (96 citations) and Aging (11 citations). Dorien Haesen has collaborated with scholars based in Belgium, Spain and Finland. Frequent co-authors include Veerle Janssens, Ward Sents, Caroline Lambrecht, Elitsa Ivanova, Katleen Lemaire, Anna Sablina, Baptiste Fischer, Etienne Waelkens, Nuno Bernardes and Péter Tompa. Their work appears in journals such as Nature Communications, Cancer Research and FEBS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026